Jean-Marc Ferran

Data Utility in Anonymised Clinical Study Reports (CSRs)

S. Nevitt, Jean-Marc Ferran, 2017 .

Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.

S. Mayer, Jean-Marc Ferran, M. C. Christensen, 2009, Stroke.

Secondary prophylaxis with recombinant activated factor VII improves health‐related quality of life of haemophilia patients with inhibitors

G. Auerswald, R. Ljung, B. Konkle, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

European Medicines Agency Policy 0070: an exploratory review of data utility in clinical study reports for academic research

S. Nevitt, Jean-Marc Ferran, 2019, BMC Medical Research Methodology.

Impact of Recombinant Activated Factor VII on Health-Related Quality of Life after Intracerebral Hemorrhage

S. Mayer, J. Broderick, T. Steiner, 2007, Cerebrovascular Diseases.

Depressed Mood after Intracerebral Hemorrhage: The FAST Trial

S. Mayer, B. Kissela, Jean-Marc Ferran, 2009, Cerebrovascular Diseases.

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

B. Biller, C. Höybye, Jean-Marc Ferran, 2023, Journal of the Endocrine Society.

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

B. Biller, C. Höybye, Jean-Marc Ferran, 2022, Endocrine connections.